Immunic (IMUX) Treasury Shares (2013 - 2014)

Immunic (IMUX) posted Treasury Shares of $12.5 million for Q1 2014, down 8.79% sequentially from $13.7 million in Q4 2013.

Analysis

Immunic (IMUX) Treasury Shares (2013 - 2014) Analysis & Trends

Immunic has reported Treasury Shares for 2 years, with the latest figure at $12.5 million in Q1 2014.

Quarterly Treasury Shares changed N/A year-over-year to $12.5 million in Q1 2014, while the trailing twelve-month figure through Mar 2014 was $12.5 million (changed N/A YoY) and the FY2013 annual result came in at $13.7 million, up 95.36% from the prior year.
Treasury Shares retreated to $12.5 million in Q1 2014 per IMUX's latest filing, from $13.7 million in the prior quarter.
Over five years, Treasury Shares peaked at $13.7 million in Q4 2013 and troughed at $12.5 million in Q1 2014.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	138.51 Bn	130.66 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.24 Bn	77.25 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	63.46 Bn	58.28 Bn	1.37 Bn	-
4	Moderna	57.89 Bn	52.75 Bn	52.00 Mn	-
5	Revolution Medicines	44.02 Bn	44.02 Bn	-	-
6	BeOne Medicines	39.95 Bn	34.85 Bn	1.53 Bn	-
7	Alnylam Pharmaceuticals	35.49 Bn	32.19 Bn	992.69 Mn	-
8	Royalty Pharma	28.43 Bn	27.59 Bn	-	2.72 Mn
9	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
10	Immunic	540.78 Mn	540.78 Mn	-	-

Historic Data

Download Data